Our study's focus on the tumour microenvironment (TME) of ccRCC, especially the role of APP in tumour‐associated macrophages (TAMs), offers novel insights into the disease's progression.14, 18. The gene discussed is APP; the disease is nonpapillary renal cell carcinoma.